- SBRI Healthcare

With Accident and Emergency pressures well reported and as waiting times reach their highest level in more than a decade, SBRI Healthcare today announced £4.3 million investment in new technologies that could reduce pressures in this vital area.

Five innovations that have potential to reduce emergency admissions via A&E through wireless monitoring and the use of self-help apps, pioneering point of care diagnostic testing, and a novel way of to manage urgent care flow have been selected. Each successful company will receive up to £1 million in financial backing to take their products to the next stage in development.

Dr Liz Mear, Chair of the AHSN Network commented: “A&E waiting times have been increasing over time with recent figures showing more than one in ten patients are waiting at least four hours for a hospital bed after emergency admission, a near five-fold increase since 2010/11. The causes of the problems in A&E, and the solutions to address them, are complex and to a great extent dependent on processes and capacity in other hospital departments, as well as other parts of the health and care system.”

SBRI Healthcare is an NHS England initiative, led by the country’s 15 Academic Health Science Networks (AHSNs), that co-develops innovative products to address unmet health needs.

The five companies selected by SBRI Healthcare for the second tranche of investment were drawn from a shortlist of 14 companies that received six months feasibility funding in March 2016. The successful companies demonstrated best value and greatest technical feasibility to a panel of experts looking for game-changing technologies with the highest potential value to patients and the health service. The companies will be supported and fully funded to continue with product development and testing.

Categories: Featured Article

Related Posts

Featured Article

Are you making the most of your pharmacy data?

Martin Hao, managing director of Healthera and Lewis Fiford, pharmacy innovation manager, explore how pharmacies can begin to use this data to their advantage to boost their business further. Pharmacies collect huge amounts of patient data, which Read more…

Featured Article

The damaging effect of the new repeat prescribing model

Martin Hao, managing director at Healthera , questions the damage the new repeat prescribing model is having on community pharmacies A controversial Clinical Commissioning Group (CCG) scheme that is banning some pharmacies from managing their Read more…

Featured Article

Pharmacies using technology to boost medical adherence

Medical adherence remains a challenge for all pharmacies but the technology is out there, as Martin Hao from Healthera explains… As consumers we are becoming ever-more curious about our health and fitness – many people Read more…